MCP Agilent Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 1, 2008.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700422-MCP200v1
7/3/591    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karamessinis, P. M
Right arrow Articles by Chrousos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karamessinis, P. M
Right arrow Articles by Chrousos, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on September 4, 2007
Revised on November 21, 2007
Accepted on December 7, 2007

Marked defects in the expression and glycosylation of alpha -2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: Proteomic screening and potential clinical implications

Panagiotis M Karamessinis, Ariadne Malamitsi-Puchner, Theodora Boutsikou, Manousos Makridakis, Konstantinos Vougas, Michael Fountoulakis, Antonia Vlahou, and George Chrousos

First Department of Pediatrics, University of Athens, Athens 115 27

Corresponding Author: chrousge{at}med.uoa.gr

Intrauterine growth restriction (IUGR) has been associated with increased perinatal morbidity and mortality and increased morbidity and metabolic abnormalities later in life. IUGR is characterized as the failure of a fetus to achieve his or her genetic growth potential in utero. Altered protein expression profiles associated with IUGR may be informative on the pathologic mechanisms of this condition and might reveal potential markers for postnatal complications. The aim of this study was to compare protein profiles of umbilical cord (UC) plasma from IUGR and appropriate for gestational age (AGA) full-term neonates. Blood samples from doubly clamped UC at delivery from ten IUGR and ten AGA full-term neonates were analyzed by two dimensional electrophoresis (2-DE) and mass spectrometry (MS). Prominent changes of the alpha-2-HS glycoprotein/fetuin-A, were observed in IUGR cases. Specifically, we show that these changes occur primarily at the level of post-translational modifications of the protein. Using a combination of mass spectrometry and classical biochemical assays, single and heavy chain forms of fetuin-A were found to lack the normally present O-linked sialic acids in IUGR neonates. Fetuin A is a glycoprotein that has been associated with promotion of in vitro cell replication, fetal growth and osteogenesis, and protection from Gram- bacterial endotoxins. Prominent defects in glycosylation/sialylation of fetuin-A revealed by our study, might be responsible for impaired function of fetuin-A, leading to deficient fetal growth, especially osteogenesis, and/or to the development of complications frequently seen later in the lives of IUGR neonates.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.